Monitoring of Enoxaparin during Hemodialysis Covered by Regional Citrate Anticoagulation in Acute Kidney Injury: A Prospective Cohort Study

Background: Current guidelines recommend the monitoring of anti-factor Xa (anti-Xa) levels to avoid an accumulation of low-molecular-weight heparins in patients with acute kidney injury, but there is no evidence on how to proceed with such monitoring during continuous renal replacement therapy. Agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiegele, Marion, Adelmann, Dieter, Dibiasi, Christoph, Pausch, Andrè, Baierl, Andreas, Schaden, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509597/
https://www.ncbi.nlm.nih.gov/pubmed/34640507
http://dx.doi.org/10.3390/jcm10194491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509597/
https://www.ncbi.nlm.nih.gov/pubmed/34640507
http://dx.doi.org/10.3390/jcm10194491

Ejemplares similares